Cost-effectiveness of different human papillomavirus vaccines in Singapore - sprookjes - yvandenbroek - TriplyDB

Cost-effectiveness of different human papillomavirus vaccines in Singapore

Cost-effectiveness of different human papillomavirus vaccines in Singapore

http://www.wikidata.org/entity/Q33859018

about

Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran.Knowledge, attitudes and practices regarding human papillomavirus vaccination among young women attending a tertiary institution in Singapore.Modeling preventative strategies against human papillomavirus-related disease in developed countries Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.Perspectives of young Chinese Singaporean women on seeking and processing information to decide about vaccinating against human papillomavirus.The clinical and economic benefits of school-based quadrivalent HPV vaccination in Singapore.The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review.Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

P2860

Q26779543-17F4D33A-B6A7-48BB-A937-4B626D5DD7D5 Q33916649-93A71ABC-23DA-4605-979C-B31AC1C6AE76 Q35484171-92359E62-00A5-4ADD-A382-029E9394B025 Q37147791-F24FE7EC-40BD-4083-A1DD-AE495016188D Q37198208-03843AE7-7667-4861-974F-12CDF38F8C49 Q37321084-D9A2E373-0F80-46CA-B677-FFF717F95C15 Q38691371-8814A1E8-AC96-4BBD-9A5C-379C6591B25D Q38965202-74E0F35D-4974-469D-9D52-94918AA0D24B Q39450074-C169AE6F-21FC-4EE6-8A74-19584059C3CF Q55540751-8E2ED958-D8A2-4BEA-A2D3-04872AB70618 Q57089346-21FF8491-683D-41D1-B992-071CADC22A75

P2860

Cost-effectiveness of different human papillomavirus vaccines in Singapore

http://www.wikidata.org/entity/Q33859018

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cost-effectiveness of different human papillomavirus vaccines in Singapore

@ast

Cost-effectiveness of different human papillomavirus vaccines in Singapore

@en

type

label

Cost-effectiveness of different human papillomavirus vaccines in Singapore

@ast

Cost-effectiveness of different human papillomavirus vaccines in Singapore

@en

prefLabel

Cost-effectiveness of different human papillomavirus vaccines in Singapore

@ast

Cost-effectiveness of different human papillomavirus vaccines in Singapore

@en

P1433

Q33859018-E5592B76-ADAD-4DDB-B27B-257D936A13F1

P1476

Q33859018-4795E3A2-73B6-4378-BF33-98D5F79C78B8

P2093

Q33859018-422C99E4-9734-46C1-B36C-F4FFA6F44EC3

Q33859018-5932545E-F281-41C8-B649-D19AC61D3183

Q33859018-72C12696-55AB-4D33-9303-2AB8808CC852

Q33859018-A07AA19F-57D2-4060-B384-F9C5B552D05D

P2860

Q33859018-0EC59825-2C28-48A0-B104-83567D1D4CA6

Q33859018-15E8C2F0-8FFD-4F1B-AACE-54614BBC01FB

Q33859018-1D361FA3-EE05-44C4-B9D0-AA88A75C453D

Q33859018-200996BC-1739-4DBA-A065-8195FC99BC4F

Q33859018-2E8B32C2-DEC3-408B-B669-01776CE85C00

Q33859018-35A99AC4-568A-42E1-B7E2-432D10A02740

Q33859018-3C39F772-9FB8-40A9-8BCE-FBB4D7442408

Q33859018-450DA859-4706-41D2-A52B-1D124C62D5A6

Q33859018-47664D10-934B-4EB5-B4CF-BFD7DB3E468C

Q33859018-544DB101-D47F-4C54-8CE8-0B037C1389EF

P2888

Q33859018-8A28665C-6492-4BFA-8D11-991C4ECCFB4C

P304

Q33859018-9FB21E36-4989-49D2-B627-51A06EEBFA62

P31

Q33859018-E1899C68-6CD8-4AC2-BC86-82D55A8BDB12

P356

Q33859018-BDE9B5BD-19F9-4F9B-9D8A-7F19BAF714CB

P407

Q33859018-CC367BA9-6BB0-4215-958D-D82962061D54

P478

Q33859018-DC3A5B7B-6A93-409E-A862-45B9937328B7

P577

Q33859018-B5A1BC3E-3D4D-4E48-93EA-0C9219243E9F

P5875

Q33859018-8794326D-D7A3-48EB-9BE3-427B231FBCFE

P6179

Q33859018-8C805845-85C8-4E63-A6DB-086D49E8EB05

P698

Q33859018-F9B9B882-F868-4A93-BE65-75FA9B81038A

P921

Q33859018-033398C4-8784-48AD-9636-1FF55E25013A

P932

Q33859018-3C355B28-549D-4376-A3FF-50DBF52631FF

P356

1471-2458-11-203

P1433

BMC Public Health

P1476

Cost-effectiveness of different human papillomavirus vaccines in Singapore

@en

P2093

Mei Yin Tok

http://www.w3.org/2001/XMLSchema#string

Sun Kuie Tay

http://www.w3.org/2001/XMLSchema#string

Vernon J Lee

http://www.w3.org/2001/XMLSchema#string

Yee Leong Teoh

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.

Economic notes. Discounting

Human papillomavirus and cervical cancer.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

P2888

1471-2458-11-203

P304

203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2458-11-203

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50938783

http://www.w3.org/2001/XMLSchema#string

P6179

1030345513

http://www.w3.org/2001/XMLSchema#string

P698

21453537

http://www.w3.org/2001/XMLSchema#string

P921

P932

3082243

http://www.w3.org/2001/XMLSchema#string